- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: HHV8 DLBCL
Total 584 results
-
Second Affiliated Hospital, School of Medicine,...CompletedDiffuse Large B-cell LymphomaChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
MorphoSys AGCompletedDiffuse Large B Cell LymphomaFrance, Italy, Spain, United States, Austria, Australia, Germany, Korea, Republic of, Canada, Denmark, Taiwan, United Kingdom
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
CelgeneWithdrawnLymphoma, B-CellKorea, Republic of, United States, Spain, Belgium, Taiwan, United Kingdom, Austria, France
-
Hoffmann-La RocheCompletedNon-Hodgkin LymphomaAlgeria, Morocco, Tunisia
-
Novartis PharmaceuticalsCompletedMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), LymphomaItaly, Australia, Germany, Spain, France, Japan, United States
-
The Lymphoma Academic Research OrganisationCompletedLymphoma | Diffuse Large B-cell LymphomaBelgium, Switzerland, France, Australia, Spain, Israel, Austria, Portugal, Poland
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
GlaxoSmithKlineHealth Research Associates, Inc.CompletedNeoplasmsUnited States
-
ImmunoVaccine Technologies, Inc. (IMV Inc.)TerminatedDiffuse Large B-Cell LymphomaCanada
-
Taiho Oncology, Inc.TerminatedMultiple Myeloma | NonHodgkin LymphomaUnited States
-
St. Petersburg State Pavlov Medical UniversityCompletedDiffuse Large B Cell LymphomaRussian Federation
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Lymphoma FollicularUnited States, Australia, Italy
-
ADC Therapeutics S.A.No longer availableRelapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
CelgeneCompletedDiffuse B-Cell LymphomaCanada, Spain, Belgium, United States
-
The Lymphoma Academic Research OrganisationCentre Henri BecquerelCompletedDiffuse Large B Cell LymphomaFrance, Belgium
-
Merck Sharp & Dohme LLCTerminated
-
Ruijin HospitalActive, not recruitingDiffuse Large B Cell LymphomaChina
-
Sun Yat-sen UniversityCompletedDiffuse Large B-cell Lymphoma
-
Acerta Pharma BVTerminatedDLBCL | Richter SyndromeUnited Kingdom, United States
-
Hoffmann-La RocheCompletedLymphomaPoland, United States, Germany
-
PfizerEMD SeronoTerminatedDiffuse Large B-Cell LymphomaUnited States, Belgium, United Kingdom, Spain, Australia, Korea, Republic of, Italy, Poland
-
Carevive Systems, Inc.CompletedFollicular Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
IncuronTerminatedHematological MalignanciesUnited States
-
miRagen Therapeutics, Inc.CompletedChronic Lymphocytic Leukemia (CLL) | Cutaneous T-cell Lymphoma (CTCL) | Mycosis Fungoides (MF) | Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype | Adult T-Cell Leukemia/Lymphoma (ATLL)United States
-
Jiangsu Cancer Institute & HospitalUnknownDiffuse Large B-Cell Lymphoma (DLBCL)China
-
Incyte CorporationCompletedRefractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited States
-
Samsung Medical CenterJanssen, LPUnknown
-
Sunesis PharmaceuticalsTerminatedFollicular Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Mantle-Cell Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Lymphoplasmacytoid LymphomaUnited States
-
George Washington UniversityWithdrawnNon-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
The Lymphoma Academic Research OrganisationTerminated
-
CelgeneCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, DiffuseUnited States
-
MorphoSys AGClinigen Healthcare LtdApproved for marketing
-
Ain Shams UniversityCompleted
-
Cancer Institute and Hospital, Chinese Academy...Enrolling by invitationDiffuse Large B Cell LymphomaChina
-
The Lymphoma Academic Research OrganisationCHU de NancyCompleted
-
Cancer Institute and Hospital, Chinese Academy...UnknownDiffuse Large B-cell Lymphoma | Rituximab | ToripalimabChina
-
Hoffmann-La RocheAbbVieCompletedLymphoma, Non-HodgkinSpain, Hungary, United States, Canada, Australia, Austria, Czechia, France, Italy, Netherlands
-
Gilead SciencesTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B-cell Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Duke UniversityCompletedDiffuse Large B-cell LymphomaUnited States
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Ruijin HospitalUnknownDiffuse Large B-Cell Lymphoma RefractoryChina
-
Nordic Lymphoma GroupMundipharma Pte Ltd.; AmgenCompletedPrimary DiseaseDenmark, Finland, Norway, Sweden
-
MedImmune LLCCompletedAcute Myeloid Leukemia | Multiple Myeloma | Diffuse Large B-cell LymphomaUnited States, France, Korea, Republic of
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Mundipharma-EDO GmbHWithdrawnRelapsed or Refractory Diffuse Large B-cell LymphomaUnited Kingdom
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States